Ranbaxy launches authorised generic version of Rocaltrol
This article was originally published in Scrip
Executive Summary
Ranbaxy Pharmaceuticals Inc, a wholly owned US subsidiary of Ranbaxy Laboratories, has launched an authorised generic version of Rocaltrol (calcitriol) in both softgel capsules and an oral liquid formulation, under an agreement with Validus Pharmaceuticals LLC.